Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.
Home > Anti-aging Research >
Antidepressants & Psychotropics > Anafranil
News & Research:
- Bad Taste Of Drugs May Affect Treatment Compliance, Study Findings Suggest - Doctor's Guide, 3/29/00 -
"four tricyclic anti-depressants Schiffman and Zervakis studied (clomipramine HCI, desipramine HCI,
doxepin HCI and imipramine HCI) produced similar taste complaints among all subjects"
- Clomipramine More Effective Than Desipramine For Body Dysmorphic Disorder - Doctor's Guide, 10/26/99 -
"Clomipramine at 25-75 mg was found to be significantly more effective than placebo in reducing
irritability as well as other symptoms associated with PMDD"
- New Guidelines To Set Standards For Best Treatment Of OCD - Doctor's Guide, 5/12/97 -
"Experts rated the side effects of the four SSRIs (fluoxetine, fluvoxamine, paroxetine and sertraline) as generally better
tolerated than the one SRI, clomipramine"
Which antidepressants have demonstrated superior efficacy? A review
of the evidence - Int Clin Psychopharmacol. 2007
Nov;22(6):323-329 - "Criteria were defined
to judge the strength of evidence. Two pivotal studies in
moderate-to-severe major depressive disorder that demonstrate
superiority on the primary efficacy measure, or alternatively one
pivotal study supported by consistent results from meta-analyses,
was considered to constitute evidence for definite superiority.
Three antidepressants met these criteria: clomipramine, venlafaxine,
and escitalopram. Three antidepressants were found to have probable
superiority: milnacipran, duloxetine, and mirtazapine. Only
escitalopram was found to have definite superiority in the treatment
of severe depression; probable superiority was identified for
venlafaxine and possible superiority for milnacipran and clomipra"